Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1515 Articles

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Douglas A. McIntyre | Oct 2, 2013 at 6:30 AM EDT

Big Pharma and 100,000 Jobs at Risk

ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…

Jon C. Ogg | Sep 30, 2013 at 10:35 AM EDT

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other,…

Jon C. Ogg | Sep 25, 2013 at 9:40 AM EDT

Short Sellers Pile On and Attack High-Yield Dividend Stocks

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Sep 10, 2013 at 12:20 PM EDT

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change…

Paul Ausick | Aug 16, 2013 at 4:06 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the…

Paul Ausick | Aug 6, 2013 at 2:03 PM EDT

Can Facebook Become the Market’s Volume Leader?

Brian Solis, via Wikimedia CommonsOn the day that Facebook Inc. (NASDAQ: FB) came public last year, more than 580 million…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 29, 2013 at 3:28 PM EDT

Pfizer Restructuring May Precede Total Breakup of the Empire

Wikimedia CommonsWhenever you see huge restructurings and reclassifications for a major corporation, the first thing that should come to mind…

Jon C. Ogg | Jul 25, 2013 at 9:35 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks

ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Paul Ausick | Jul 19, 2013 at 2:50 PM EDT

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

ThinkstockStephen A. Cohen, the founder and owner of SAC Capital Advisors LLC, has been charged by the U.S. Securities and…

Paul Ausick | Jul 12, 2013 at 4:07 PM EDT

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

July 12, 2013: U.S. equity markets opened slightly higher this morning as European industrial production was below expectations and U.S.…

Jon C. Ogg | Jul 12, 2013 at 8:25 AM EDT

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, July 12, 2013.…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

1 … 71 72 73 74 75 … 101

Pfizer : PFE

All Pfizer Articles

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Pfizer : PFE

All Pfizer Articles

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line